Mekhail TM, Abou-jawde RM, Boumerhi G, et al. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol. 2005;23(4):832-41.

Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17(8):2530-40.

Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 2002 Jan 1;20(1):289-96.

Yildiz I, Sen F, Kilic L, et al. Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma. Curr Oncol. 2013;20(6):e546-53.

Dr. Tarek Mekhail

Mekhail Extension of the Motzer Score

time

radiation

mets

<p>Predicts metastatic renal cell carcinoma survival, more accurately than the Motzer Score.</p>

Mekhail Extension

The Mekhail Extension of the Motzer Score predicts metastatic renal cell carcinoma (RCC) survival, more accurately than the Motzer Score.

MSKCC/Motzer Criteria for RCC

Thakar Score

IMDC Model for mRCC

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function